These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 25084117

  • 1. Continuation of dabigatran therapy in "real-world" practice in Hong Kong.
    Ho MH, Ho CW, Cheung E, Chan PH, Hai JJ, Chan KH, Chan EW, Leung GK, Tse HF, Siu CW.
    PLoS One; 2014; 9(8):e101245. PubMed ID: 25084117
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong.
    Ho JC, Chang AM, Yan BP, Yu CM, Lam YY, Lee VW.
    Clin Cardiol; 2012 Dec; 35(12):E40-5. PubMed ID: 23108916
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation.
    Yap LB, Rusani BI, Umadevan D, Muhammad Z, Hussin A, Kaur S, Omar R.
    J Thromb Thrombolysis; 2014 Jul; 38(1):39-44. PubMed ID: 24197653
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 10. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.
    J Stroke Cerebrovasc Dis; 2012 Apr 03; 21(3):165-73. PubMed ID: 22440950
    [Abstract] [Full Text] [Related]

  • 11. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
    Shevelev VI, Kanorskiĭ SG.
    Kardiologiia; 2012 Sep 01; 52(7):56-60. PubMed ID: 22839715
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV, Zateĭshchikov DA.
    Kardiologiia; 2014 Sep 01; 54(2):79-85. PubMed ID: 24888206
    [No Abstract] [Full Text] [Related]

  • 20. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr 01; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.